ELECTRONIC CONTINUING EDUCATION FOR
SPECIALISTS IN POISON INFORMATION

Module X -  A Review of Beta Adrenergic Receptor Antagonists

INTRODUCTION

Welcome to the American Association of Poison Control Center’s electronic continuing education program for Specialists in Poison Information.  This fourteen-day module will provide a review of beta-adrenergic receptor antagonists.
release date - 12/4/98
most recent review date - 12/4/98
 

LEARNING OBJECTIVES

In regard to beta-adrenergic receptor antagonists, upon completion of this electronic continuing education module the participant will be able to:

1.  Describe their mechanism of toxicity

2.  Describe their pharmacokinetic characteristics

3.  Discuss selected clinical features.

4.  Discuss the treatment of selected clinical features
 

AUTHOR

Daniel J. Cobaugh, PharmD
 

AUTHOR   DECLARATIONS

NO DISCLOSURES have been made by the author(s) of this module that could be perceived as a real or apparent conflict of interest in the context of the subject of their presentation(s).
 

REVIEW PANEL

Peter Ciancaglini, PharmD
Prashant Joshi, MD
Ruth Lawrence, MD
Christine Stork, PharmD
Paul Wax, MD
 

REFERENCES

Wolf LR:   Adrenergic Blocker Toxicity, in Haddad L, Shannon MW, Winchester JF (eds):  Clinical Management of Poisoning and Drug Overdose, ed 3.  Pennsylvania:  WB Sanders Co, 1998:1031-1040.

Lefkowitz RJ, Hoffman BB, Taylor P:  Neurotransmission:  The Autonomic and Somatic Motor Nervous Systems, in Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG (eds):  Goodman & Gilman’s The Pharmacological Basis of  Therapeutics, ed 9.  New York:  McGraw-Hill, 1996:105-139.

Kerns II W, Kline J, Ford MD.  Blocker and calcium channel blocker toxicity.  Emerg Med Clinics of NA 1994;12:2:365-390.
 
 

CERTIFICATION

The University of Rochester School of Medicine and Dentistry is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians.

The University of Rochester School of Medicine and Dentistry designates this educational activity for a maximum of 3.0 hours in Category 1 credit towards the AMA Physician's Recognition Award.  Each physician should claim only those hours of credit that he/she actually spent in the educational activity.

This CME activity was planned and produced in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education.